Similarly, ROR2 functions as a survival kinase that contributes to the resistance of HeLa cervical carcinoma cells to apoptosis [65], and it has been proposed as a target for melanoma and osteosarcoma therapy [63], [66]. Here, ROR2 is linked to melanoma.